8-K Announcements
6Material company update
Apr 15, 2026·SEC
Material company update
Mar 31, 2026·SEC
Material company update
Mar 17, 2026·SEC
LENSAR, Inc.(LNSR)Earnings, Financials & Key Ratios
LNSR•NASDAQ
$5.39
$65M mkt cap·Price updated May 6, 2026
AboutLENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.Show more
- Revenue$58M+9.2%
- EBITDA-$20M-198.1%
- Net Income-$34M-9.2%
- EPS (Diluted)-2.87-5.1%
- Gross Margin46.41%-4.0%
- EBITDA Margin-34.36%-172.9%
- Operating Margin-42.06%-111.0%
- Net Margin-58.66%
LNSR Key Insights
LENSAR, Inc. (LNSR) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Strong 5Y sales CAGR of 17.2%
✗Weaknesses
- ✗Profits declining 11.6% over 5 years
- ✗Weak Piotroski F-Score: 3/9
- ✗Negative free cash flow
- ✗Weak momentum: RS Rating 4 (bottom 4%)
- ✗Low quality earnings: Net income not backed by cash flow
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
LNSR Price & Volume
LENSAR, Inc. (LNSR) stock price & volume — 10-year historical chart
Loading chart...
LNSR Growth Metrics
LENSAR, Inc. (LNSR) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years17.24%
3 Years18.23%
TTM9.24%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-9.16%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-6.62%
Return on Capital
10 Years-38.54%
5 Years-34.67%
3 Years-34.42%
Last Year-59.84%
LNSR Recent Earnings
LENSAR, Inc. (LNSR) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 3/12 qtrs (25%)●Beat Revenue 7/12 qtrs (58%)
Q4 2025Latest
Nov 6, 2025EPS
$0.31
Est $0.10
-210.0%
Revenue
$14M
Est $20M
-29.5%
Q3 2025
Aug 7, 2025EPS
$0.15
Est $0.08
-87.5%
Revenue
$14M
Est $18M
-21.5%
Q2 2025
May 8, 2025EPS
$2.32
Est $0.15
-1446.7%
Revenue
$14M
Est $13M
+5.7%
Q1 2025
Feb 27, 2025EPS
$1.61
Est $0.18
-794.4%
Revenue
$17M
Est $14M
+19.5%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q4 2025Latest | Nov 6, 2025 | $0.31vs $0.10-210.0% | $14Mvs $20M-29.5% |
| Q3 2025 | Aug 7, 2025 | $0.15vs $0.08-87.5% | $14Mvs $18M-21.5% |
| Q2 2025 | May 8, 2025 | $2.32vs $0.15-1446.7% | $14Mvs $13M+5.7% |
| Q1 2025 | Feb 27, 2025 | $1.61vs $0.18-794.4% | $17Mvs $14M+19.5% |
Based on last 12 quarters of dataView full earnings history →
LNSR Peer Comparison
LENSAR, Inc. (LNSR) competitors in Vision, dental, and ENT devices — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 NVCR | 1.88B | 16.50 | -13.52 | 8.28% | -25.66% | -50.82% | 0.85 | |
 ALGN | 12.46B | 173.94 | 30.79 | 0.9% | 10.5% | 10.7% | 0.03 | |
 ATRC | 1.42B | 28.01 | -116.71 | 14.88% | -0.83% | -0.95% | 0.18 | |
 LMAT | 2.51B | 110.22 | 43.74 | 13.53% | 24.35% | 16.19% | 0.47 | |
 OMCL | 1.99B | 43.76 | 987.81 | 6.53% | 1.67% | 1.64% | 0.17 | |
 ABT | 149.97B | 86.25 | 11.29 | 4.59% | 31.88% | 27.26% | 0.32 | |
 BSX | 83.23B | 56.00 | 28.87 | 19.87% | 14.4% | 12.4% | 0.51 | |
 SYK | 111.96B | 292.33 | 34.80 | 11.16% | 12.92% | 15.04% | 0.66 |
Compare LNSR vs Peers
LENSAR, Inc. (LNSR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
LNSR Income Statement
LENSAR, Inc. (LNSR) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 24.39M | 30.53M | 26.38M | 34.46M | 35.36M | 42.16M | 53.49M | 58.44M |
| Revenue Growth % | - | 25.18% | -13.58% | 30.62% | 2.61% | 19.25% | 26.87% | 9.24% |
| Cost of Goods Sold | 14.78M | 17.3M | 12.31M | 16.63M | 15.4M | 21.06M | 27.64M | 31.31M |
| COGS % of Revenue | 60.59% | 56.67% | 46.65% | 48.25% | 43.56% | 49.94% | 51.68% | 53.59% |
| Gross Profit | 9.61M▲ 0% | 13.23M▲ 37.6% | 14.07M▲ 6.4% | 17.83M▲ 26.7% | 19.95M▲ 11.9% | 21.11M▲ 5.8% | 25.85M▲ 22.5% | 27.12M▲ 4.9% |
| Gross Margin % | 39.41% | 43.33% | 53.35% | 51.75% | 56.44% | 50.06% | 48.33% | 46.41% |
| Gross Profit Growth % | - | 37.64% | 6.4% | 26.7% | 11.9% | 5.77% | 22.48% | 4.92% |
| Operating Expenses | 18.93M | 25.94M | 32.58M | 37.48M | 40.13M | 33.34M | 36.52M | 51.7M |
| OpEx % of Revenue | 77.61% | 84.98% | 123.48% | 108.78% | 113.5% | 79.06% | 68.26% | 88.47% |
| Selling, General & Admin | 16.14M | 17.15M | 23.77M | 23.89M | 27.17M | 26.1M | 26.49M | 45.16M |
| SG&A % of Revenue | 66.19% | 56.17% | 90.09% | 69.32% | 76.84% | 61.9% | 49.52% | 77.28% |
| Research & Development | 2.78M | 7.57M | 7.55M | 12.36M | 11.81M | 6.14M | 5.33M | 5.62M |
| R&D % of Revenue | 11.42% | 24.79% | 28.63% | 35.86% | 33.41% | 14.56% | 9.96% | 9.62% |
| Other Operating Expenses | 0 | 1.23M | 1.26M | 1.24M | 1.15M | 1.1M | 4.7M | 921K |
| Operating Income | -9.32M▲ 0% | -12.71M▼ 36.5% | -18.5M▼ 45.5% | -19.65M▼ 6.2% | -20.18M▼ 2.7% | -12.23M▲ 39.4% | -10.66M▲ 12.8% | -24.58M▼ 130.5% |
| Operating Margin % | -38.2% | -41.65% | -70.13% | -57.03% | -57.06% | -29% | -19.94% | -42.06% |
| Operating Income Growth % | - | -36.47% | -45.52% | -6.22% | -2.67% | 39.39% | 12.79% | -130.45% |
| EBITDA | -4.73M | -8.85M | -15.43M | -16.89M | -16.77M | -8.71M | -6.73M | -20.08M |
| EBITDA Margin % | -19.38% | -28.98% | -58.49% | -49.01% | -47.43% | -20.67% | -12.59% | -34.36% |
| EBITDA Growth % | - | -87.22% | -74.41% | -9.43% | 0.69% | 48.04% | 22.72% | -198.13% |
| D&A (Non-Cash Add-back) | 4.59M | 3.87M | 3.07M | 2.76M | 3.41M | 3.52M | 3.93M | 4.5M |
| EBIT | -9.25M | -12.66M | -18.43M | -19.65M | -20.18M | -12.23M | -6.94M | -24.58M |
| Net Interest Income | 0 | -2M | -1.34M | 34K | 17K | 85K | 103K | 91K |
| Interest Income | 3.27M | 0 | 0 | 34K | 17K | 85K | 103K | 91K |
| Interest Expense | 0 | 2M | 1.34M | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | -3.26M | -1.94M | -1.27M | 51K | 263K | -2.15M | -20.74M | -9.7M |
| Pretax Income | -12.57M▲ 0% | -14.66M▼ 16.6% | -19.77M▼ 34.9% | -19.6M▲ 0.9% | -19.91M▼ 1.6% | -14.38M▲ 27.8% | -31.4M▼ 118.3% | -34.28M▼ 9.2% |
| Pretax Margin % | -51.55% | -48.01% | -74.95% | -56.88% | -56.32% | -34.11% | -58.71% | -58.66% |
| Income Tax | 20K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | -0.16% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -12.59M▲ 0% | -14.66M▼ 16.4% | -19.77M▼ 34.9% | -19.6M▲ 0.9% | -19.91M▼ 1.6% | -14.38M▲ 27.8% | -31.4M▼ 118.3% | -34.28M▼ 9.2% |
| Net Margin % | -51.64% | -48.01% | -74.95% | -56.88% | -56.32% | -34.11% | -58.71% | -58.66% |
| Net Income Growth % | - | -16.39% | -34.91% | 0.87% | -1.6% | 27.77% | -118.34% | -9.16% |
| Net Income (Continuing) | -12.59M | -14.66M | -19.77M | -19.6M | -19.91M | -14.38M | -31.4M | -34.28M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -11.77▲ 0% | -1.57▲ 86.7% | -1.81▼ 15.3% | -2.10▼ 16.0% | -1.96▲ 6.7% | -1.31▲ 33.2% | -2.73▼ 108.4% | -2.87▼ 5.1% |
| EPS Growth % | - | 86.66% | -15.29% | -16.02% | 6.67% | 33.16% | -108.4% | -5.13% |
| EPS (Basic) | -11.77 | -1.57 | -1.81 | -2.10 | -1.96 | -1.31 | -2.73 | -2.87 |
| Diluted Shares Outstanding | 1.07M | 10.64M | 10.93M | 9.37M | 10.16M | 10.97M | 11.52M | 11.96M |
| Basic Shares Outstanding | 1.07M | 10.64M | 10.93M | 9.37M | 10.16M | 10.97M | 11.52M | 11.96M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - |
LNSR Balance Sheet
LENSAR, Inc. (LNSR) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 11.75M | 17.18M | 58.38M | 44.81M | 33.72M | 46.44M | 41.98M | 46.77M |
| Cash & Short-Term Investments | 3.34M | 4.62M | 40.6M | 31.64M | 14.67M | 24.06M | 22.45M | 17.98M |
| Cash Only | 3.34M | 4.62M | 40.6M | 31.64M | 14.67M | 20.62M | 16.26M | 12.97M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 3.44M | 6.19M | 5M |
| Accounts Receivable | 3.3M | 3.89M | 2.46M | 4.99M | 6.24M | 4.32M | 6.48M | 6.38M |
| Days Sales Outstanding | 49.42 | 46.46 | 33.98 | 52.83 | 64.42 | 37.43 | 44.21 | 39.83 |
| Inventory | 4.06M | 8.06M | 13.47M | 6.49M | 11.74M | 15.69M | 11.43M | 21.52M |
| Days Inventory Outstanding | 100.33 | 170.15 | 399.58 | 142.43 | 278.2 | 271.95 | 150.9 | 250.85 |
| Other Current Assets | 472K | 0 | 0 | 0 | 1.06M | 2.37M | 1.62M | 896K |
| Total Non-Current Assets | 17.14M | 17.35M | 20.73M | 21.65M | 22.13M | 23.14M | 24.32M | 24.66M |
| Property, Plant & Equipment | 3.62M | 2.15M | 4.42M | 7.45M | 6.88M | 10.28M | 664K | 505K |
| Fixed Asset Turnover | 6.74x | 14.19x | 5.98x | 4.63x | 5.14x | 4.10x | 80.56x | 115.71x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 12.29M | 13.37M | 12.11M | 10.87M | 12.12M | 11.03M | 6.11M | 5.19M |
| Long-Term Investments | 753K | 0 | 0 | 0 | 442K | 492K | 1.16M | 0 |
| Other Non-Current Assets | 476K | 1.84M | 4.21M | 3.34M | 3.13M | 1.34M | 16.38M | 18.96M |
| Total Assets | 28.89M▲ 0% | 34.54M▲ 19.6% | 79.12M▲ 129.1% | 66.47M▼ 16.0% | 55.84M▼ 16.0% | 69.58M▲ 24.6% | 66.3M▼ 4.7% | 71.43M▲ 7.7% |
| Asset Turnover | 0.84x | 0.88x | 0.33x | 0.52x | 0.63x | 0.61x | 0.81x | 0.82x |
| Asset Growth % | - | 19.56% | 129.09% | -15.99% | -15.98% | 24.61% | -4.73% | 7.74% |
| Total Current Liabilities | 7.66M | 7.83M | 8.47M | 8.71M | 11.42M | 11.63M | 15M | 40.57M |
| Accounts Payable | 1.41M | 1.58M | 2.48M | 2.69M | 5.42M | 4.01M | 6M | 18.98M |
| Days Payables Outstanding | 34.88 | 33.27 | 73.58 | 59.14 | 128.48 | 69.46 | 79.16 | 221.26 |
| Short-Term Debt | 653K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 871K | 777K | 923K | 904K | 768K | 1.35M | 1.68M | 3.07M |
| Other Current Liabilities | 1.98M | 4.67M | 2.97M | 3.38M | 3.52M | 4.01M | 5M | 15.05M |
| Current Ratio | 1.53x | 2.19x | 6.90x | 5.14x | 2.95x | 3.99x | 2.80x | 1.15x |
| Quick Ratio | 1.00x | 1.16x | 5.30x | 4.40x | 1.92x | 2.64x | 2.04x | 0.62x |
| Cash Conversion Cycle | 114.88 | 183.33 | 359.98 | 136.13 | 214.13 | 239.93 | 115.95 | 69.42 |
| Total Non-Current Liabilities | 41.69M | 57.26M | 3.44M | 2.87M | 2.44M | 10.78M | 32.65M | 56.88M |
| Long-Term Debt | 41.21M | 20.2M | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 333K | 3.31M | 2.8M | 2.27M | 1.75M | 2.09M | 1.99M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 479K | 36.73M | 129K | 69K | 167K | 9.03M | 30.56M | 54.89M |
| Total Liabilities | 49.35M | 65.09M | 11.91M | 11.59M | 13.86M | 22.41M | 47.65M | 97.45M |
| Total Debt | 41.21M | 20.53M | 3.81M | 3.31M | 2.8M | 2.31M | 2.61M | 2.73M |
| Net Debt | 37.87M | 15.92M | -36.79M | -28.32M | -11.87M | -18.31M | -13.65M | -10.24M |
| Debt / Equity | - | - | 0.06x | 0.06x | 0.07x | 0.05x | 0.14x | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - |
| Interest Coverage | - | -6.32x | -13.76x | - | - | - | - | - |
| Total Equity | -20.46M▲ 0% | -30.55M▼ 49.3% | 67.21M▲ 320.0% | 54.88M▼ 18.3% | 41.98M▼ 23.5% | 47.18M▲ 12.4% | 18.65M▼ 60.5% | -26.02M▼ 239.5% |
| Equity Growth % | - | -49.29% | 319.98% | -18.35% | -23.5% | 12.37% | -60.48% | -239.54% |
| Book Value per Share | -19.13 | -2.87 | 6.15 | 5.85 | 4.13 | 4.30 | 1.62 | -2.18 |
| Total Shareholders' Equity | -20.46M | -30.55M | 67.21M | 54.88M | 41.98M | 47.18M | 18.65M | -26.02M |
| Common Stock | 96K | 11K | 109K | 110K | 111K | 113K | 116K | 120K |
| Retained Earnings | -23.53M | -38.19M | -57.99M | -77.59M | -97.51M | -111.89M | -143.29M | -177.57M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -23.53M | 0 | 0 | 0 | 0 | 4K | 6K | 4K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
LNSR Cash Flow Statement
LENSAR, Inc. (LNSR) cash flow — operating, investing & free cash flow history
| Line item | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -1.89M | -12.59M | -13.79M | -8.97M | -14.86M | -9.66M | -2.27M | -14.83M |
| Operating CF Margin % | -7.73% | -41.24% | -52.27% | -26.03% | -42.02% | -22.91% | -4.25% | -25.38% |
| Operating CF Growth % | - | -567.85% | -9.55% | 34.96% | -65.64% | 34.98% | 76.45% | -551.91% |
| Net Income | -12.59M | -14.66M | -19.77M | -19.6M | -19.91M | -14.38M | -31.4M | -34.28M |
| Depreciation & Amortization | 4.59M | 3.87M | 2.56M | 2.76M | 3.41M | 3.52M | 3.93M | 4.5M |
| Stock-Based Compensation | 1.32M | 102K | 9.04M | 6.87M | 6.61M | 5.54M | 2.67M | 3.14M |
| Deferred Taxes | 0 | -78K | 57K | 527K | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 9.15M | 537K | 505K | 517K | 618K | 3.45M | 25.58M | 10.7M |
| Working Capital Changes | 5.92M | -2.36M | -6.19M | -42K | -5.58M | -7.78M | -3.04M | 1.1M |
| Change in Receivables | 443K | 14K | 1.33M | -2.65M | -1.44M | 1.08M | -2.1M | 289K |
| Change in Inventory | -876K | -4.77M | -8.7M | 2.33M | -6.89M | -7.46M | -4.9M | -13.9M |
| Change in Payables | 663K | 127K | 910K | 213K | 2.73M | -1.42M | 1.96M | 12.99M |
| Cash from Investing | -3.89M | -2.09M | -326K | -354K | -115K | -4.16M | -2.16M | 1.28M |
| Capital Expenditures | -3.25M | -2.09M | -366K | -354K | -115K | -236K | -156K | -83K |
| CapEx % of Revenue | 13.32% | 6.84% | 1.39% | 1.03% | 0.33% | 0.56% | 0.29% | 0.14% |
| Acquisitions | -644K | 0 | 40K | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - |
| Other Investing | -644K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 6.96M | 15.95M | 50M | 361K | -1.99M | 19.76M | 78K | 10.26M |
| Debt Issued (Net) | 3.5M | 13.22M | 12.4M | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 3.87M | 3.83M | 39.46M | 361K | 408K | 13.88M | 58K | 258K |
| Dividends Paid | -198K | -31K | -1.86M | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -214K | -1.07M | 0 | 0 | -2.4M | 5.88M | 20K | 10M |
| Net Change in Cash | 1.18M▲ 0% | 1.27M▲ 7.9% | 35.88M▲ 2723.3% | -8.96M▼ 125.0% | -16.96M▼ 89.3% | 5.95M▲ 135.1% | -4.36M▼ 173.3% | -3.29M▲ 24.5% |
| Free Cash Flow | -5.13M▲ 0% | -14.68M▼ 186.0% | -14.16M▲ 3.5% | -9.32M▲ 34.1% | -14.97M▼ 60.6% | -9.89M▲ 33.9% | -2.43M▲ 75.4% | -14.91M▼ 513.5% |
| FCF Margin % | -21.05% | -48.08% | -53.66% | -27.06% | -42.34% | -23.47% | -4.54% | -25.52% |
| FCF Growth % | - | -185.95% | 3.55% | 34.15% | -60.58% | 33.91% | 75.43% | -513.49% |
| FCF per Share | -4.80 | -1.38 | -1.29 | -0.99 | -1.47 | -0.90 | -0.21 | -1.25 |
| FCF Conversion (FCF/Net Income) | 0.15x | 0.86x | 0.70x | 0.46x | 0.75x | 0.67x | 0.07x | 0.43x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 19K | 3K | 18K | 24K | 42K |
LNSR Key Ratios
LENSAR, Inc. (LNSR) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | - | -107.89% | -32.11% | -41.12% | -32.26% | -95.42% | - |
| Return on Invested Capital (ROIC) | -40.15% | -689.23% | -175.84% | -51.74% | -53.41% | -31.1% | -47.24% | - |
| Gross Margin | 39.41% | 43.33% | 53.35% | 51.75% | 56.44% | 50.06% | 48.33% | 46.41% |
| Net Margin | -51.64% | -48.01% | -74.95% | -56.88% | -56.32% | -34.11% | -58.71% | -58.66% |
| Debt / Equity | - | - | 0.06x | 0.06x | 0.07x | 0.05x | 0.14x | - |
| Interest Coverage | - | -6.32x | -13.76x | - | - | - | - | - |
| FCF Conversion | 0.15x | 0.86x | 0.70x | 0.46x | 0.75x | 0.67x | 0.07x | 0.43x |
| Revenue Growth | - | 25.18% | -13.58% | 30.62% | 2.61% | 19.25% | 26.87% | 9.24% |
LNSR SEC Filings & Documents
LENSAR, Inc. (LNSR) SEC filings — annual & quarterly reports (10-K, 10-Q)
LNSR Frequently Asked Questions
LENSAR, Inc. (LNSR) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
LENSAR, Inc. (LNSR) reported $58.4M in revenue for fiscal year 2025. This represents a 140% increase from $24.4M in 2018.
LENSAR, Inc. (LNSR) grew revenue by 9.2% over the past year. This is steady growth.
LENSAR, Inc. (LNSR) reported a net loss of $34.3M for fiscal year 2025.
Dividend & Returns
LENSAR, Inc. (LNSR) had negative free cash flow of $14.9M in fiscal year 2025, likely due to heavy capital investments.
Explore More LNSR
LENSAR, Inc. (LNSR) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates